
Browsing restrictions can be lifted for a fee.
Based on the latest data from August 2025, Oracle (ORCL) is trading at $226.13, positioning the stock in the "Warning" zone above the 53.6x PE multiple boundary of $239.29. The stock is trading between the 45.6x PE multiple ($203.29) and the 53.6x PE multiple ($239.29), indicating severe overvaluation according to historical PE standards. This represents a significant premium to Oracle's historical valuation ranges, with the current price substantially exceeding the "Fair" valuation zone (29.4x PE at $131.24) and even surpassing the "Overvalued" threshold (37.5x PE at $167.29). Oracle's valuation has undergone a dramatic expansion over the analyzed period, transitioning from relatively modest PE multiples in 2020-2022 to extreme valuations by 2024-2025. During the early pandemic period (2020-2021), the stock primarily traded within the "Undervalued" to "Fair" zones, with prices often below the 21.4x PE boundary. A notable inflection point occurred in mid-2023, when Oracle began consistently trading above the 29.4x PE "Fair" valuation threshold. The most significant valuation expansion occurred in 2024, particularly from June onwards, when the stock price surged from around $132 to over $239 by July 2025, pushing it into the highest PE multiple territory. This represents a fundamental shift in market perception, with Oracle now commanding premium valuations typically reserved for high-growth technology companies, suggesting investors are pricing in substantial future growth expectations or benefiting from AI-related market enthusiasm.